Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard L. Franklin currently holds 8,330 shares of Pathfinder Cell Therapy, Inc. (PFND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard L. Franklin has been a net seller of PFND stock. They have purchased $115.7K and sold $980.1K worth of shares.
Richard L. Franklin's most recent insider trade was on Oct 25, 2016, when they sold 8,330 shares at $9.00 per share.
Richard L. Franklin serves as Executive at Pathfinder Cell Therapy, Inc. (PFND). They have executed 40 insider transactions totaling $1.1M over their tenure at the company.
Richard L. Franklin holds the position of Executive at Pathfinder Cell Therapy, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Richard L. Franklin has shown a selling trading pattern, with $115.7K in total purchases and $980.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard L. Franklin was on Mar 3, 2014, when they sold $170.5K worth of RPTP shares. This transaction involved 10,715 shares at $15.91 per share.
Richard L. Franklin currently owns 8,330 shares of Pathfinder Cell Therapy, Inc. (PFND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard L. Franklin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard L. Franklin has 40 Form 4 filings on record as an insider at Pathfinder Cell Therapy, Inc..
Set alerts for Richard L. Franklin and 40,000+ other insiders.